Li-Bin Huang

发表

Improved outcome for Chinese children with acute promyelocytic leukemia: A comparison of two protocols

Xue-Qun Luo, Zhi-yong Ke, Xiao-qing Guan, 2009, Pediatric blood & cancer.

Arsenic trioxide induces autophagic degradation of the FLT3-ITD mutated protein in FLT3-ITD acute myeloid leukemia cells

Xue-Qun Luo, Jie Luo, Zhi-yong Ke, 2020, Journal of Cancer.

Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children’s Leukemia Group

Y. Li, Yang Li, N. Liao, 2022, Frontiers in Oncology.

Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathway

Wenlin Huang, Xue-Qun Luo, Wuguo Deng, 2016, Oncotarget.

The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1

Wentao Wang, Yumeng Sun, Xue-Qun Luo, 2022, Cell Discovery.

Combination of C-Reactive Protein and Procalcitonin in Distinguishing Fungal from Bacterial Infections Early in Immunocompromised Children

Yingli Liu, Zhi-yong Ke, Yanlai Tang, 2022, Antibiotics.

Maintenance therapy with dose‐adjusted 6‐mercaptopurine in idiopathic pulmonary hemosiderosis

Xue-Qun Luo, Jia Zhu, Zhi-yong Ke, 2008, Pediatric pulmonology.

MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia

Liang-Hu Qu, Ling Xu, Li-Bin Huang, 2009, PloS one.

The comparison of outcome and cost of three protocols for childhood non‐high risk acute lymphoblastic leukemia in China

Xue-Qun Luo, Jia Zhu, Zhi-yong Ke, 2008, Pediatric blood & cancer.

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia

Hua Zhang, Jun Wu, Zhi-yong Ke, 2013, Cancer Cell International.

Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group

Chi-kong Li, Xiang He, N. Liao, 2021, Frontiers in Oncology.

Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways

Xue-Qun Luo, Zhi-yong Ke, Yanlai Tang, 2017, Leukemia & lymphoma.

Five Chinese Pediatric Patients with Leukemias Possibly Arising from Immature Natural Killer Cells: Clinical Features and Courses

Ling Xu, Xue-Qun Luo, Zhi-yong Ke, 2011, Pediatric hematology and oncology.

High‐risk childhood acute lymphoblastic leukemia in China: Factors influencing the treatment and outcome

Xue-Qun Luo, Zhi-yong Ke, Xiao-qing Guan, 2009, Pediatric blood & cancer.

Flavokawain B inhibits the growth of acute lymphoblastic leukemia cells via p53 and caspase-dependent mechanisms

Xue-Qun Luo, Wuguo Deng, Zhi-yong Ke, 2015, Leukemia & lymphoma.

Current status of diagnosis and prognosis of infant acute leukemia in China

Xue-Qun Luo, Zhi-yong Ke, Xiao-qing Guan, 2009, Pediatric blood & cancer.

Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study

Ke Huang, Xue-Qun Luo, Jie Luo, 2018, American journal of hematology.

The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia

Xue-Qun Luo, Jie Luo, D. Huang, 2022, Cancer Chemotherapy and Pharmacology.

MTHFR-C677T Gene Polymorphism and Susceptibility to Acute Lymphoblastic Leukemia in Children: A Meta-Analysis.

Xue-Qun Luo, Y. Pei, Zhi-yong Ke, 2020, Critical reviews in eukaryotic gene expression.

Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD

D. Huang, Xue-Qun Luo, Yanlai Tang, 2020, Leukemia & lymphoma.

Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-κB/COX-2 signaling pathways.

Wenlin Huang, Xue-Qun Luo, Wuguo Deng, 2019, Cancer letters.

Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD‐ALL‐2008): An open‐label, multicentre, randomized, phase III clinical trial

Chi-kong Li, Jianpei Fang, Y. Ruan, 2023, American journal of hematology.

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia

Hua Zhang, Jun Wu, Xue-Qun Luo, 2013, Cancer Cell International.

MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor

Li-Bin Huang, Xue-Qun Luo, Yue-Qin Chen, 2017, The Journal of Steroid Biochemistry and Molecular Biology.

Obesity as the initial manifestation of central nervous system relapse of acute lymphoblastic leukemia: case report and literature review.

Xue-Qun Luo, Zhi-yong Ke, Yan-hong Li, 2012, Journal of cancer research and therapeutics.

Differentiation syndrome and coagulation disorder — comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia

Xue-Qun Luo, Jie Luo, W. Wan, 2023, Annals of Hematology.

Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol

N. Liao, Dun-Hua Zhou, Li-na Wang, 2023, Hematology.

Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238

Xue-Qun Luo, Jie Luo, Yanlai Tang, 2020, Hematology.

Improved outcome for Chinese children with acute promyelocytic leukemia: A comparison of two protocols

Xue-Qun Luo, Zhi-yong Ke, Xiao-qing Guan, 2009, Pediatric blood & cancer.

Case Report: CD19 and CD20 monoclonal antibodies with sequential chemotherapy for refractory acute B-lymphocytic leukemia in children

Xue-Qun Luo, Yanlai Tang, Li-na Wang, 2023, Frontiers in immunology.

Intensive chemotherapy with dual induction and ALL-like consolidation for childhood acute myeloid leukemia: a respective report from multiple centers in China

Zhi-yong Ke, Yanlai Tang, Li-na Wang, 2024, Therapeutic Advances in Hematology.